Description

Book Synopsis
Presents a discussion on decision making in the reimbursement of pharmaceuticals.

Table of Contents
Introduction.

Development of marketing authorisation procedures for pharmaceuticals.

Interpreting clinical evidence.

International pharmaceutical policy - health creation or wealth creation?.

The development of fourth hurdle policies around the world.

Economic modelling in drug reimbursement.

Priority-setting in health care: matching decision criteria with policy objectives.

The tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral.

sclerosis.

Relationship between stakeholders: managing the war of the words.

Medicines and the media: good information or misleading hype?.

How to promote quality use of cost-effective medicines.

Making it happen and making it sustainable.

Pricing of pharmaceuticals.

Evaluating pharmaceuticals for health policy in low and middle income country settings

Evaluating Pharmaceuticals for Health Policy and

    Product form

    £84.56

    Includes FREE delivery

    RRP £93.95 – you save £9.39 (9%)

    Order before 4pm tomorrow for delivery by Wed 5 Aug 2026.

    A Paperback / softback by Nick Freemantle, Suzanne Hill

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Evaluating Pharmaceuticals for Health Policy and by Nick Freemantle

      Publisher: John Wiley & Sons Inc
      Publication Date: Publication Date: 26/07/2004
      ISBN13: 9780727917843, 978-0727917843
      ISBN10: 0727917846

      Description

      Book Synopsis
      Presents a discussion on decision making in the reimbursement of pharmaceuticals.

      Table of Contents
      Introduction.

      Development of marketing authorisation procedures for pharmaceuticals.

      Interpreting clinical evidence.

      International pharmaceutical policy - health creation or wealth creation?.

      The development of fourth hurdle policies around the world.

      Economic modelling in drug reimbursement.

      Priority-setting in health care: matching decision criteria with policy objectives.

      The tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral.

      sclerosis.

      Relationship between stakeholders: managing the war of the words.

      Medicines and the media: good information or misleading hype?.

      How to promote quality use of cost-effective medicines.

      Making it happen and making it sustainable.

      Pricing of pharmaceuticals.

      Evaluating pharmaceuticals for health policy in low and middle income country settings

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account